Organisation: Position: Deadline Date: Location:


October 18th, 2017 Taking oral vitamin D supplements in addition to standard asthma medication could halve the risk of asthma attacks requiring hospital attendance, according to research led by Queen Mary University of London (QMUL). Asthma affects more than 300m...

October 18th, 2017 More than half (57%) of cancer drugs authorised by the European Medicines Agency (EMA) between 2009 and 2013 came onto the market without any clear evidence they improved the quality or quantity of patients’ lives, according to research from...

Weekly Roundup



Discharge delays may be cause of sharp rise in deaths in the UK

The increased prevalence delays in discharge from hospital was associated with the sharp rise in mortality in England in 2015, accounting for up to a fifth of mortality increases. UK researchers believe they have found evidence that poorer... October 18th, 2017


HIV: The benefits of INH prophylaxis for TB are confirmed

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries. This prophylactic use of drugs reduces mortality, even among people taking... October 18th, 2017

Protease inhibitor regimen maintains viral suppression for a year

People who switched from a multi-pill antiretroviral regimen to the first one-pill, once-daily regimen that includes a protease inhibitor maintained undetectable viral load for a year, according to a report at the recent IDWeek 2017 conference in... October 18th, 2017

ART in Africa bridges health gap between those with, without HIV

The expansion of ART for HIV infection has helped reduce disparities in health-related quality of life between HIV-positive and HIV-negative individuals in Zambia and South Africa, Healio reports according to study findings. “Little evidence... October 18th, 2017


Ebola vaccine tested on adults and children in Africa

Data confirms the acceptable safety and immunogenicity profile of the rVSV-ΔGP-ZEBOV Eboal virus in adults and support consideration of lower doses for paediatric populations, a University of London found. The worst Ebola virus disease outbreak... October 18th, 2017

Clofazimine protects against TB in brain and central nervous system

A recently published paper has highlighted the potential of clofazimine to protect the brain and central nervous system against extra-pulmonary TB, according to one of the researchers, Dr Sooraj Baijnath, senior lecturer in pharmaceutical sciences... October 18th, 2017


Simple oral swab test could revolutionise TB detection in children

At the 48th Union World Conference on Lung Health, a diagnostic test for tuberculosis (TB) has been presented that is simple, potentially ground-breaking, yet very low-tech. Oral swab analysis (OSA) is a novel alternative to sputum analysis for... October 18th, 2017


Ingestible sensor to transform TB treatment adherence methods

A new, “digitised medicine” could revolutionise the way patients are treated for tuberculosis (TB), according to the results of a study announced at the 48th Union World Conference on Lung Health. Data released show Wireless Observed Therapy... October 18th, 2017

New drugs to treat MDR-TB not available to all

Sinethemba Kuse, 18, invited her friends and family to a celebratory party on 22 September. But, says a Daily Maverick report, it wasn’t a birthday or graduation: the Khayelitsha teenager had taken the last of her TB medication. Kuse was... October 18th, 2017

Case for more effective, less toxic and shorter MDR-TB treatments

Recently released research bolsters the case for more effective, less toxic and shorter treatment regimens for drug-resistant tuberculosis, offering hope for patients suffering from a disease that is notoriously difficult to treat. The Wall Street... October 18th, 2017


Men finding 'bromances' more emotionally satisfying than romances

Young men's 'bromances,' close friendships with other men, are more emotionally satisfying than their romantic relationships with women, finds a small University of Winchester study. Study authors led by Stefan Robinson at the department of sport... October 18th, 2017

Gossip is essential for interpersonal relationships

Intrasexual competition positively predicted gossip frequency with women reporting a greater tendency to gossip in comparison to men, particularly about physical appearance and social information, whereas men reported gossiping more about... October 18th, 2017


Poison shrub warning after Limpopo kids are hospitalised

Scientists have issued a warning about a shrub common in at least three of South Africa’s provinces after four children were poisoned by its seeds, reports The Times. The children‚ aged between two and six‚ were playing in Limpopo when... October 18th, 2017


'Magic mushroom' compound reduces depression symptoms

Patients taking psilocybin to treat depression show reduced symptoms for up to five weeks after treatment following a 'reset' of their brain activity. The findings come from a study in which researchers from Imperial College London used... October 18th, 2017


New drug reduces gout flares

Researchers report that the drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout. Febuxostat treatment also reduced synovitis – or inflammation of the joint lining detected by MRI scanning... October 18th, 2017


HiRIT safe for post-menopausal women with low bone mass

Contrary to current opinion, High-intensity resistance and impact training (HiRIT) was efficacious and induced no adverse events for otherwise healthy post-menopausal women with low to very low bone mass. Exercise is known to be beneficial to... October 18th, 2017

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.